[HTML][HTML] Therapeutic Perspectives on ROCK Inhibition for Cerebral Cavernous Malformations
TL Montagnoli, DR de Oliveira, CAM Fraga - Kinases and Phosphatases, 2023 - mdpi.com
Cerebral cavernous malformations (CCM) are developmental venous dysplasias which
present as abnormally dilated blood vessels occurring mainly in the brain. Alterations in …
present as abnormally dilated blood vessels occurring mainly in the brain. Alterations in …
Role of rho-associated kinase in the pathophysiology of cerebral cavernous malformations
Cerebral cavernous malformations (CCMs) are vascular lesions characterized by a porous
endothelium. The lack of a sufficient endothelial barrier can result in microbleeds and frank …
endothelium. The lack of a sufficient endothelial barrier can result in microbleeds and frank …
Kinases in cerebral cavernous malformations: Pathogenesis and therapeutic targets
Cerebral cavernous malformations (CCMs) are low-flow, hemorrhagic vascular lesions of
the central nervous system of genetic origin, which can cause stroke-like symptoms and …
the central nervous system of genetic origin, which can cause stroke-like symptoms and …
A brain-targeted orally available ROCK2 inhibitor benefits mild and aggressive cavernous angioma disease
L McKerracher, R Shenkar, M Abbinanti, Y Cao… - Translational stroke …, 2020 - Springer
Cavernous angioma (CA) is a vascular pathology caused by loss of function in one of the 3
CA genes (CCM1, CCM2, and CCM3) that result in rho kinase (ROCK) activation. We …
CA genes (CCM1, CCM2, and CCM3) that result in rho kinase (ROCK) activation. We …
Current and Future Treatment Options for Cerebral Cavernous Malformations
L Morrison, J Gutierrez, C Ayata… - Stroke: Vascular and …, 2024 - Am Heart Assoc
Cerebral cavernous malformations (CCMs) are vascular lesions associated with seizures,
hemorrhage, and neurologic deficits. The familial form of CCM constitutes≈ 20% of cases …
hemorrhage, and neurologic deficits. The familial form of CCM constitutes≈ 20% of cases …
Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling
BT Richardson, CF Dibble, AL Borikova… - Biological …, 2013 - degruyter.com
Cerebral cavernous malformation (CCM) involves the homozygous inactivating mutations of
one of three genes, ccm1,-2, or-3 resulting in hyperpermeable blood vessels in the brain …
one of three genes, ccm1,-2, or-3 resulting in hyperpermeable blood vessels in the brain …
Fasudil slows development of cavernous malformations
GM Weiner, AF Ducruet - Neurosurgery, 2017 - journals.lww.com
Cavernous malformations (CCM) are endothelium-lined sinusoidal channels filled with
blood. CCMs have a prevalence 0.4% to 0.6% and exhibit an annual hemorrhage rate of …
blood. CCMs have a prevalence 0.4% to 0.6% and exhibit an annual hemorrhage rate of …
Familial cerebral cavernous malformations
surface interactions between these as well as with numerous binding partners. 17 FCCM is
inherited in an autosomal dominant fashion, with every affected parent having a 50 …
inherited in an autosomal dominant fashion, with every affected parent having a 50 …
Emerging pharmacologic targets in cerebral cavernous malformation and potential strategies to alter the natural history of a difficult disease: a review
Importance Cerebral cavernous malformations (CCMs) are vascular lesions of the brain that
may lead to hemorrhage, seizures, and neurologic deficits. Most are linked to loss-of …
may lead to hemorrhage, seizures, and neurologic deficits. Most are linked to loss-of …
[HTML][HTML] Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype
AL Borikova, CF Dibble, N Sciaky, CM Welch… - Journal of Biological …, 2010 - ASBMB
Cerebral cavernous malformations (CCM) are vascular lesions causing seizures and stroke.
Mutations causing inactivation of one of three genes, ccm1,-2, or-3, are sufficient to induce …
Mutations causing inactivation of one of three genes, ccm1,-2, or-3, are sufficient to induce …